Patents by Inventor Jason Metzner
Jason Metzner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240033492Abstract: A layered microneedle device can have successively stacked layers that each include microneedles and perforations positioned between the microneedles. The layers can be stacked to permit microneedles of a lower layer to extend through the perforations of an upper layer. Thus, microneedles of successively stacked layers can extend away from individual layers in a common direction.Type: ApplicationFiled: April 4, 2023Publication date: February 1, 2024Applicant: Allergan, Inc.Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Publication number: 20220080170Abstract: A layered microneedle device can have successively stacked layers that each include microneedles and perforations positioned between the microneedles. The layers can be stacked to permit microneedles of a lower layer to extend through the perforations of an upper layer. Thus, microneedles of successively stacked layers can extend away from individual layers in a common direction.Type: ApplicationFiled: April 26, 2021Publication date: March 17, 2022Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Patent number: 10987503Abstract: A skin treatment can include applying a microneedle device to a region of the skin so that microneedles of the device penetrate the stratum corneum. The arrangement of microneedles can have first microneedles with a first length and second microneedles with a second length, different from the first length. The first and second microneedles can be formed from a mixture of a polymeric material and an active agent beneficial to skin. After the device is applied to the skin, the first and second microneedles can be released below the skin surface, followed by dissolution of the first and second microneedles.Type: GrantFiled: March 30, 2020Date of Patent: April 27, 2021Assignee: ALLERGAN, INC.Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Publication number: 20200316356Abstract: A skin treatment can include applying a microneedle device to a region of the skin so that microneedles of the device penetrate the stratum corneum. The arrangement of microneedles can have first microneedles with a first length and second microneedles with a second length, different from the first length. The first and second microneedles can be formed from a mixture of a polymeric material and an active agent beneficial to skin. After the device is applied to the skin, the first and second microneedles can be released below the skin surface, followed by dissolution of the first and second microneedles.Type: ApplicationFiled: March 30, 2020Publication date: October 8, 2020Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Patent number: 10603477Abstract: A skin treatment device is provided including bioerodible polymeric microneedles which are designed to more effectively deliver beneficial agents to the skin. The device includes a flexible substrate and an arrangement, for example, an array, of microneedles projecting from the substrate.Type: GrantFiled: February 23, 2018Date of Patent: March 31, 2020Assignee: Allergan, Inc.Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Publication number: 20190358566Abstract: Lipoaspirate can be treated for use in fat grafting procedures. For example, the lipoaspirate can be placed in a container having an inlet for receiving the lipoaspirate and an outlet for dispensing and removal of desired materials from the lipoaspirate. The inlet and the outlet can be located on a common side of first and second filter elements. An activation mechanism can be actuated to move the first filter element relative to the second filter element within the container to separate cellular components of the lipoaspirate from non-cellular components of the lipoaspirate.Type: ApplicationFiled: August 5, 2019Publication date: November 28, 2019Inventors: Zachary DOMINGUEZ, Justin SCHWAB, Tiago BERTOLOTE, Jason METZNER, Ethan FRANKLIN
-
Patent number: 10369500Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: GrantFiled: February 1, 2016Date of Patent: August 6, 2019Assignee: Allergan, Inc.Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Publication number: 20180229017Abstract: A skin treatment device is provided including bioerodible polymeric microneedles which are designed to more effectively deliver beneficial agents to the skin. The device includes a flexible substrate and an arrangement, for example, an array, of microneedles projecting from the substrate.Type: ApplicationFiled: February 23, 2018Publication date: August 16, 2018Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Publication number: 20180133401Abstract: Described are devices, systems, and methods for processing adipose tissue for reintroduction into a body. In some embodiments, adipose tissue is mixed with an additive prior to reintroduction.Type: ApplicationFiled: January 11, 2018Publication date: May 17, 2018Inventors: Justin SCHWAB, Mike AUGARTEN, Darin MESSINA, Jason METZNER, Ethan FRANKLIN
-
Patent number: 9867939Abstract: Described are devices, systems, and methods for processing adipose tissue for reintroduction into a body. In some embodiments, adipose tissue is mixed with an additive prior to reintroduction.Type: GrantFiled: March 11, 2014Date of Patent: January 16, 2018Assignee: Allergan, Inc.Inventors: Justin Schwab, Mike Augarten, Darin Messina, Jason Metzner, Ethan Franklin
-
Patent number: 9801747Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: GrantFiled: January 29, 2015Date of Patent: October 31, 2017Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Justin J. Schwab, Mitchell H. Babkes, Jason Metzner, Zachary P. Dominguez
-
Publication number: 20170258617Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: ApplicationFiled: May 30, 2017Publication date: September 14, 2017Applicant: Apollo Endosurgery US, Inc.Inventors: Justin J. Schwab, Mitchell H. Babkes, Jason Metzner, Zachary P. Dominguez
-
Patent number: 9681974Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: GrantFiled: October 21, 2014Date of Patent: June 20, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Patent number: 9655757Abstract: Generally described herein are apparatus, systems and methods related to a novel esophageal device implantable in the patient's body and designed to replicate the restrictive and satiety mechanism associated with gastric banding systems known in the art. The device can be a compliant and tubular-shaped and fixated within the gastro-esophageal lumen using tissue anchors.Type: GrantFiled: October 5, 2015Date of Patent: May 23, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Justin Schwab, Zachary Dominguez, Jason Metzner
-
Publication number: 20160279401Abstract: A skin treatment device is provided including bioerodible polymeric microneedles which are designed to more effectively deliver beneficial agents to the skin. The device includes a flexible substrate and an arrangement, for example, an array, of microneedles projecting from the substrate.Type: ApplicationFiled: March 27, 2015Publication date: September 29, 2016Inventors: Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
-
Publication number: 20160144302Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: ApplicationFiled: February 1, 2016Publication date: May 26, 2016Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Patent number: 9248384Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: GrantFiled: October 2, 2013Date of Patent: February 2, 2016Assignee: Allergan, Inc.Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Publication number: 20150142044Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: ApplicationFiled: January 29, 2015Publication date: May 21, 2015Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Mitchell H. Babkes, Jason Metzner, Zachary P. Dominguez
-
Publication number: 20150094753Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: ApplicationFiled: October 21, 2014Publication date: April 2, 2015Applicant: APOLLO ENDOSURGERY, INC.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Publication number: 20150093362Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: ApplicationFiled: October 2, 2013Publication date: April 2, 2015Applicant: Allegran, Inc.Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin